Ginkgo Bioworks Holdings Stock Net Asset
DNA Stock | USD 0.53 0.03 5.36% |
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
Ginkgo | Net Asset |
Ginkgo Bioworks Holdings Company Net Asset Analysis
Ginkgo Bioworks' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Ginkgo Bioworks Net Asset | 1.67 B |
Most of Ginkgo Bioworks' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ginkgo Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Net Asset. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
Ginkgo Total Assets
Total Assets |
|
Based on the recorded statements, Ginkgo Bioworks Holdings has a Net Asset of 1.67 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Ginkgo Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ginkgo Bioworks' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics of similar companies.Ginkgo Bioworks is currently under evaluation in net asset category among related companies.
Ginkgo Bioworks Institutional Holders
Institutional Holdings refers to the ownership stake in Ginkgo Bioworks that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ginkgo Bioworks' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ginkgo Bioworks' value.Shares | Glenview Capital Management Llc | 2024-03-31 | 24 M | Geode Capital Management, Llc | 2024-03-31 | 21.9 M | Norges Bank | 2023-12-31 | 14.8 M | Legal & General Group Plc | 2024-03-31 | 11.4 M | Millennium Management Llc | 2024-03-31 | 10.6 M | Exor Investments (uk) Llp | 2024-03-31 | 10 M | Charles Schwab Investment Management Inc | 2024-03-31 | 7.9 M | Welch & Forbes Llc | 2024-03-31 | 7 M | Northern Trust Corp | 2024-03-31 | 6 M | Baillie Gifford & Co Limited. | 2024-03-31 | 233 M | Ark Investment Management Llc | 2024-03-31 | 189.6 M |
Ginkgo Fundamentals
Return On Equity | -0.66 | ||||
Return On Asset | -0.22 | ||||
Operating Margin | (4.69) % | ||||
Current Valuation | 562.72 M | ||||
Shares Outstanding | 1.71 B | ||||
Shares Owned By Insiders | 6.44 % | ||||
Shares Owned By Institutions | 82.86 % | ||||
Number Of Shares Shorted | 274.44 M | ||||
Price To Earning | 25.51 X | ||||
Price To Book | 1.98 X | ||||
Price To Sales | 8.65 X | ||||
Revenue | 251.46 M | ||||
Gross Profit | 273.49 M | ||||
EBITDA | (600.68 M) | ||||
Net Income | (892.87 M) | ||||
Cash And Equivalents | 1.32 B | ||||
Cash Per Share | 0.84 X | ||||
Total Debt | 241.77 M | ||||
Debt To Equity | 0.03 % | ||||
Current Ratio | 11.84 X | ||||
Book Value Per Share | 0.46 X | ||||
Cash Flow From Operations | (295.5 M) | ||||
Short Ratio | 4.70 X | ||||
Earnings Per Share | (0.43) X | ||||
Target Price | 1.43 | ||||
Number Of Employees | 1.22 K | ||||
Beta | 1.42 | ||||
Market Capitalization | 1.17 B | ||||
Total Asset | 1.67 B | ||||
Retained Earnings | (5.29 B) | ||||
Working Capital | 837.89 M | ||||
Current Asset | 10.07 B | ||||
Current Liabilities | 3.1 B | ||||
Net Asset | 1.67 B |
About Ginkgo Bioworks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Revenue Per Share 0.106 | Quarterly Revenue Growth (0.53) | Return On Assets (0.22) | Return On Equity (0.66) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.